Editorial Review

Kidney International (1997) 51, 16–26; doi:10.1038/ki.1997.3

Renal cysts, renal cancer and von Hippel-Lindau disease

Hartmut P H Neumann1 and Berton Zbar1

1Albert-Ludwigs-Universität, Freiburg, Germany and National Cancer Institute, Frederick, Maryland, USA

Correspondence: Prof Dr Hartmut P H Neumann, Medizinische Universitätsklinik, Hugstetter Strabetae 55, D 79106 Freiburg, Germany. E-mail: Neumann@mm41.ukl.uni-freiburg.de

Received 7 February 1996; Revised 5 August 1996; Accepted 5 August 1996.

Top

References

  1. Melmon KL, Rosen SW: Lindau's disease: Review of the literature and study of a large kindred. Am J Med 36:595–617, 1964 | Article | PubMed | ChemPort |
  2. Neumann HPH: Basic criteria for clinical diagnosis and genetic counselling in Von Hippel-Lindau syndrome. J Vas Dis 16:220–226, 1987
  3. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 283:1151–1163, 1990
  4. Maher ER, Iselius L, Yates JRW, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N: Von Hippel-Lindau disease: A genetic study. J Med Genet 28:443–447, 1991 | PubMed | ISI | ChemPort |
  5. Neumann HPH, Wiestler OD: Clustering of features of the von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 337:1052–1054, 1991 | Article | PubMed | ISI | ChemPort |
  6. Neumann HPH: Pheochromocytomas multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med 330:1091–1092, 1994
  7. Hippel E von: Über eine sehr seltene Erkrankung der Netzhaut. Albrecht von Graefes Arch Ophthal 59:83–86, 1904
  8. Hippel E von: Die anatomische Grundlage der von mir beschriebenen "sehr seltenen Erkrankung der Netzhaut." Albrecht von Graefes Arch Ophthal 79:350–377, 1911
  9. Brandt R: Zur Frage der Angiomatosis retinae. Albrecht von Graefes Arch Ophthal 106:127–165, 1921
  10. Lindau A: Studien über Kleinhirnzysten: Bau Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Pathol Microbiol Scand (Suppl I):1–129, 1926
  11. Neumann HPH, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BAJ, Crossey PA, Maher ER, Brauch H: Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2. JAMA 274:1149–1151, 1995 | Article | PubMed | ChemPort |
  12. Poston CD, Jaffe GS, Lubensky IA, Solomon D, Zbar B, Linehan WM, Walther MM: Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: Clinical and molecular genetic implications. J Urol 153:22–26, 1995 | Article | PubMed | ChemPort |
  13. Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, Skinner DG, Ersig D, Richie JP, de Kernion JB, Marshall F, Marsch CL: Treatment of renal cell carcinoma in Von Hippel-Lindau disease: A multicenter study. J Urol 153:1812–1816, 1995 | Article | PubMed | ISI | ChemPort |
  14. Keeler LL, Klauber GT: Von Hippel-Lindau disease and renal cell carcinoma in a 16-year-old boy. J Urol 147:1588–1591, 1992
  15. Choyke PL, Glenn GM, Walther MM, Zbar B, Weiss GH, Alexander RB, Hayes WS, Long JP, Tahore KN, Linehan WM: The natural history of renal lesions in von Hippel-Lindau disease; a serial CT study in 28 patients. Am J Roentgenol 159:1229–1234, 1992 | ChemPort |
  16. Solomon D, Schwartz A: Renal pathology in von Hippel-Lindau disease. Hum Pathol 19:1072–1079, 1988
  17. Bernstein J, Evan AP, Gardner KD: Epithelial hyperplasia in human polycystic kidney diseases. Am J Pathol 129:92–101, 1987 | PubMed | ISI | ChemPort |
  18. Ibrahim RE, Weinberg DS, Weidner N: Atypical cysts and carcinomas of the kidneys in the phacomatoses. Cancer 63:148–157, 1989
  19. Goodbody RA, Gamlen TR: Cerebellar hemangioblastoma and genitourinary tumors. J Neurol Neurosurg Psychiatr 37:606–609, 1974
  20. Andrew SM, Gradwell E: Immunoperoxidase labelled antibody taining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas. J Clin Pathol 39:917–919, 1986 | PubMed | ChemPort |
  21. Neumann HPH, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Vakhloo AK, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P, Wiestler OD: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatr 55:898–901, 1992
  22. Clelland CA, Treip CS: Histological differentiation of metastatic renal carcinoma in the cerebellum from cerebellar hemangioblastoma in von Hippel-Lindau's disease. J Neurol Neurosurg Psychiatr 52:162–166, 1989
  23. Frimodt-Møller PC, Nissen HM, Dyreborg U: Polycystic kidneys as renal lesion in Lindau disease. J Urol 125:868–870, 1981
  24. Keith DS, Torres VE, King BF, Zinckl H, Farrow GM: Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 4:1661–1669, 1994
  25. Neumann HPH, Dinkel E, Brambs HJ, Wimmer B, Friedburg H, Volk B, Sigmund G, Riegler P, Haag K, Schollmeyer P, Wiestler OD: Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology 101:465–471, 1991
  26. Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Hawley L: Report of the diagnostic criteria committee of the national tuberous sclerosis association. J Child Neurol 7:221–224, 1992 | PubMed | ISI | ChemPort |
  27. Mullin EM, Devere White R, Peterson LJ, Paulson DF: Bilateral renal carcinoma in von Hippel-Lindau disease. Urology 8:475–478, 1976
  28. Fetner CD, Barilla DE, Scott T, Ballard J, Peters P: Bilateral renal cell carcinoma in von Hippel-Lindau syndrome: treatment with staged bilateral nephrectomy and hemodialysis. J Urol 117:534–536, 1977
  29. Ture F de: Urologic implications in von Hippel-Lindau syndrome. Urology 11:612–615, 1978
  30. Pearson JC, Weiss J, Tanagho EA: A plea for conservation of kidney in renal adenocarcinoma associated with von Hippel-Lindau disease. J Urol 124:910–912, 1980 | PubMed | ChemPort |
  31. Novick AC, Streem SB: Long-term follow-up after nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease. J Urol 147:1488–1490, 1992 | PubMed | ChemPort |
  32. Lund GO, Fallon B, Curtis MA, Williams RD: Conservative surgical therapy of localized renal cell carcinoma in Von Hippel-Lindau disease. Cancer 74:2541–2545, 1994 | PubMed | ChemPort |
  33. Neumann HPH, Wiestler OD: Von Hippel-Lindau disease: A syndrome providing insights into growth control and tumorigenesis. Nephrol Dial Transplant 9:1832–1833, 1994
  34. Mcdougall EM, Clayman RV, Elashry UM: Laparoscopic radical nephrectomy for renal tumor: The Washington University experience. J Urol 155:1180–1185, 1996
  35. Peterson GJ, Codd JE, Cuddihee RE, Newton WT: Renal transplantation in von Hippel-Lindau disease. Arch Surg 112:841–842, 1977
  36. Beerman MH, Fromkes J, Carey LC, Thomas FB: Pancreatic cystadenoma in von Hippel-Lindau disease; an unusual cause of pancreatic and common bile duct obstruction. J Clin Gastrol 4:537–540, 1983
  37. Binkowitz LA, Johnson CD, Stephens DH: Islet cell tumor in von Hippel-Lindau disease: Increased prevalence and relationship to the multiple endocrine neoplasias. Am J Roentgenol 155:501–505, 1990
  38. Karsdorp N, Elderson A, Wittebol-Post D, Hené RJ, Vos J, Feldberg MAM, van Hils APG, Jansen-Schillhorn, van Veen JM, Vroom TM, Höppener JWM, Lips CJM: Von Hippel-Lindau Disease: New strategies in early detection and treatment. Am J Med 97:157–168, 1994
  39. Lamiell JM, Salazar FG, Hsia YE: Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 68:1–29, 1989 | PubMed |
  40. Levine E, Collins DL, Horon WA, Schimke RN: Computed tomographic screening of the abdomen in von Hippel-Lindau disease. Am J Roentgenol 139:505–510, 1982
  41. Neumann HPH, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B, Kirste G: Pheochromocytomas. multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med 329:1531–1538, 1993 | Article | PubMed | ISI | ChemPort |
  42. Resche F, Moisan JP, Mantoura J, De Kersaint-Hilly A, André MJ, Perrin-Resche I, Menegalli-Boggelli D, Lajat Y, Richard S: Haemangioblastoma, haemangioblastomatosis and von Hippel-Lindau disease. Adv Techn Stand Neurosurg 20:197–304, 1993
  43. Ridley M, Green J, Johnson G: Retinal angiomatosis: the ocular manifestations of von Hippel-Lindau disease. Can J Ophthalmol 21:276–283, 1986
  44. Zbar B, Kishida T, Chen F, Schmidt L, Maher AR, Richards FM, Crossey PA, Webster A, Affara NA, Ferguson-Smith MA, Brauch H, Neumann HPH, Tisherman S, Mulvihill JJ, Gross D, Shuin T, Whaley J, Seizinger BR, Kley N, Olschwang S, Boisson C, Richard S, Lips CJM, Linehan WM, Lerman M: Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America Europe and Japan. Hum Mutation (in press)
  45. Knudson AG: All in the (cancer) family. Nature Genet 5:103–104, 1993 | Article |
  46. Kovacs G: Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62:89–124, 1993 | PubMed | ISI | ChemPort |
  47. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS: Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301:592–595, 1979 | PubMed | ISI | ChemPort |
  48. Zbar B, Brauch H, Talmadge C, Linehan WM: Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721–724, 1987 | Article | PubMed | ChemPort |
  49. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Muller-Brechlin R, Klein G, Sumegi J: Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85:1571–1575, 1988 | PubMed |
  50. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JWM, Collins D, Majoor-Krakauer D, Bonner T, Mathew C, Rubenstein A, Halperin J, Mcconkie-Rosell A, Green JS, Trofatter JA, Ponder BA, Eierman L, Bowmer MI, Schimke R, Oostra B, Aronin N, Smith DI, Drabkin H, Waziri MH, Hobbs WJ, Martuza RL, Conneally PM, Hsia YE, Gusella JF: Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269, 1988 | Article | PubMed | ISI | ChemPort |
  51. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Glenn G, Choyke P, Walther MM, Weng Y, Duan DSR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI: Identification of the Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320, 1993 | Article | PubMed | ISI | ChemPort |
  52. Hosoe S, Brauch H, Latif F, Glenn G, Daniel L, Bale S, Choyke P, Gorin M, Oldfield E, Berman A, Goodman J, Orcutt ML, Hampsch K, Delisio J, Modi W, Mcbride W, Anglard P, Weiss G, Walther MM, Linehan WM, Lerman MI, Zbar B: Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8:634–640, 1991
  53. Richards FM, Maher ER, Latif F, Phipps ME, Tory K, Lush M, Crossey PA, Oostra B, Gustavson KH, Green J, Turner G, Yates JRW, Linehan M, Affara NA, Lerman M, Zbar B, Ferguson-Smith MA: Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene. J Med Genet 30:104–107, 1993
  54. Yao M, Latif F, Orcutt ML, Kuzmin I, Stackhouse T, Zhou FW, Tory K, Duh FM, Richards F, Maher E, Laforgia S, Huebner K, Le Pasilier D, Linehan M, Lerman M, Zbar B: Von Hippel-Lindau disease: Identification of deletion mutations by pulsed-field gel electrophoresis. Hum Genet 92:605–614, 1993
  55. Zbar B: Von Hippel-Lindau disease and sporadic renal cell carcinoma. Cancer Surveys 25:219–232, 1995
  56. Smith KJ: The APC gene product in normal and tumor cells. PNAS USA 90:2846–2850, 1991
  57. Mike Y, Swensen J, Shattuck-Eidens D, Futreal A, Harschman K, Tautigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, Mcclure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami A, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick M: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71, 1994
  58. Takahashi H, Behbakht K, Mcgovern PE, Chui H-C, Couch FJ, Weber BL, Friedman LS, King MC, Furusato M, Li, Volsi VA, Menzin AW, Liu PC, Benjamin I, Morgan MA, King SA, Rebane BA, Cardonick A, Mikuta JJ, Rubin SC, Boyd J: Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998–3002, 1995 | PubMed | ISI | ChemPort |
  59. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS: Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nature Genet 9:439–443, 1995 | Article |
  60. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, Collins FS, Weber BL: Mutations in the BRCA1 gene in families with early-onset breast and ovarian carcinoma. Nature Genet 8:387–391, 1994 | Article |
  61. Vogelstein B, Kinzler KW: Has the breast cancer gene been found? Cell 79:1–3, 1994 | Article | PubMed | ISI | ChemPort |
  62. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc J-F, Belanger C, Dion F, Liu Q, Skolnick M, Goldgar D, Shattuch-Eidens D, Lbria F, Narod SA: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet 8:392–398, 1994 | Article |
  63. Srivastava S, Zou A, Pirollo K, Blattner W, Chang E: Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747–749, 1990 | Article | PubMed | ISI | ChemPort |
  64. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend S: Germline p53 mutations in a familial syndrome of breast cancer sarcomas and other neoplasms. Science 250:1233–1238, 1990 | Article | PubMed | ISI | ChemPort |
  65. Levine AJ, Perry MR, Chang A, Silver A, Dittmer D, Wu M, Welsh D: The role of the p53 tumor suppressor gene in tumorigenesis. Br J Cancer 69:409–416, 1994 | PubMed | ISI | ChemPort |
  66. Duan DR, Humphrey JS, Chen CYT, Weng Y, Sukegawa J, Lee S, Gnarra JR, Linehan WM, Klausner RD: Characterization of the VHL tumor suppressor gene product: Localization complex formation and the effect of naturally inactivating mutations. Proc Nat Acad Sci USA 92:6459–6363, 1995
  67. Kishida T, Stackhouse T, Chen F, Lerman MI, Zbar B: Cellular proteins that bind the von Hippel-Lindau disease gene product: Mapping the binding domains and the effect of missense mutations. Cancer Res 55:4544–4548, 1995 | PubMed | ISI | ChemPort |
  68. Duan DR, Pause A, Burgess WH, Aso T, Chen CYT, Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402–1406, 1995 | Article | PubMed | ISI | ChemPort |
  69. Kibel A, Iliopoulos O, Decaprio JA, Kaelin WG JR: Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269:1444–1446, 1995 | Article | PubMed | ISI | ChemPort |
  70. Iliopoulos O, Kibel A, Gray S, Kaelin WG JR: Tumor suppression by the human von Hippel-Lindau gene product. Nature Med 1:822–826, 1995 | Article |
  71. Lee S, Chen DYT, Humphrey JS, Gnarra JR, Linehan WM, Klausner RD: Nuclear/cytoplasmic lokalization of the VHL tumor suppressor gene product is determined by cell density. PNAS USA 93:1770–1775, 1996
  72. Garrett KP, Aso T, Bradsher JN, Foundling SI, Lane WS, Conaway RC, Conaway JW: Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc Natl Acad Sci USA 92:7172–7176, 1995 | Article | PubMed | ChemPort |
  73. Bradsher JN, Jackson KW, Conaway RC, Conaway JW: RNA polymerase II transcription factor SIII. I. Identification purification and properties. J Biol Chem 268:25587–25593, 1993 | PubMed | ISI | ChemPort |
  74. Bradsher JN, Tan S, Mclaury H-J, Conaway JW, Conaway RC: RNA polymerase II transcription factor SIII. II. Functional properties and role in RNA chain elongation. J Biol Chem 268:25594–25603, 1993 | PubMed | ISI | ChemPort |
  75. Garrett KP, Haque D, Connaway RC, Conaway JW: A human cDNA encoding the small subunit of RNA polymerase II transcription factor SIII. Gene 150:413–414, 1994 | Article | PubMed | ISI | ChemPort |
  76. Garrett KP, Tan S, Bradsher JN, Lane WS, Conaway JW, Conaway RC: Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII. Proc Natl Acad Sci USA 91:5237–5241, 1994 | Article | PubMed | ChemPort |
  77. Aso T, Lane WS, Conaway JW, Conaway RC: Elongin (siii): A multisubunit regulator of elongation by RNA polymerase II. Science 269:1439–1443, 1995 | Article | PubMed | ISI | ChemPort |
  78. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D: Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by Von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299–2301, 1996 | PubMed | ISI | ChemPort |
  79. Wizigmann-Voss S, Brier G, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor and its receptors in Von Hippel-Lindau associated and sporadic hemangioblastomas. Cancer Res 55:1358–1364, 1995
  80. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Höfler H, Latif F, Lerman MI, Zbar B, Neumann HPH: Nucleotide 505 germline mutation in the VHL tumor suppressor gene correlates with pheochromocytoma in von Hippel-Lindau disease. Hum Genet 95:551–556, 1995 | Article | PubMed | ISI | ChemPort |
  81. Knudson AG JR: Genetics of human cancer. Ann Rev Genet 20:231–251, 1986 | Article | PubMed | ISI |
  82. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan D-HR, Gnarra JR, Linehan WM, Baylin SB: Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. PNAS USA 91:9700–9704, 1994
  83. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HPH, Laidlaw J, Lee FP, Klein-Szanto AJP, Seizinger BR, Kley N: Germline mutations in the VHL tumor suppressor gene are similar to somatic VHL aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092–1102, 1994 | PubMed | ISI | ChemPort |
  84. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MW, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzati R, Walther MM, Bander MH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet 7:85–90, 1994 | Article |
  85. Chen F, Kishida T, Yao M, Hustand T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Lineham WM, Lerman M, Zbar B: Germ line mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype. Hum Mut 5:66–75, 1995
  86. Henkind P, Benjamin JV: Vascular anomalies and neoplasms of the optic nerve head. Trans Ophthal Soc UK 96:418–423, 1976
  87. Blamires TL, Maher ER: Choroid plexus papilloma. A new presentation of von Hippel-Lindau (VHL) disease. Eye 6:90–92, 1992
  88. Horton WA, Wong V, Eldridge R: Von Hippel-Lindau disease. Arch Int Med 136:769–777, 1976
  89. Kadir S, Kerr WS, Athanasoulis CA: The role of arteriography in the management of renal cell carcinoma associated with Von Hippel-Lindau disease. J Urol 126:316–319, 1981
  90. Burns C, Levine PH, Reichman H, Stock JL: Case report: Adrenal hemangioblastoma in Von Hippel-Lindau disease as a cause of secondary erythrocytosis. Am J Med Sci 30:119–121, 1987
  91. Cendron M, Wein AJ, Schwartz SS, Murtagh F, Livolski VA, Tomaszewski JE: Germ cell tumor of testis in a patient with von Hippel-Lindau disease. Urology 37:69–71, 1991
  92. Gersell DJ, King TC: Papillary cystadenoma of the mesosalpinx in Von Hippel-Lindau disease. Am J Surg Pathol 12:145–149, 1988
  93. Korn WT, Schatzki SC, Disciullo AJ, Scully RE: Papillary cystadenoma of the broad ligament in von Hippel-Lindau disease. Am J Obstet Gynecol 163:596–598, 1990
  94. Goodman, Kleinholz JG, Peck FC: Lindau disease in the Hudson valley. J Neurosurg 21:97–103, 1964

Extra navigation

.
ADVERTISEMENT